Medications

FDA approves first cell-based gene therapy for beta-thalassemia

The U.S. Food and Drug Administration has approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood ...

Diseases, Conditions, Syndromes

Cognitive impairment predicts outcomes for ICU survivors

For intensive care unit survivors, cognitive impairment at hospital discharge is associated with the risk of new physical disability at six-month follow-up, according to a study published in the July issue of the American ...

page 5 from 27